Moderna Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Okay. Good morning, everyone. I'm Geoff Meacham. I'm the senior biopharma analyst here at Bank of America. I have also for my team, Alec Stranahan. And welcome to the BofA London Healthcare Conference. We have a great session for you today. We have Moderna with us. And speaking on behalf of Moderna, we have CEO, Stéphane Bancel.
So the format for today is just a fireside chat. And we do have access to the Veracast technology. If you want to log in a question, I can see questions in the queue and then I can read those out as well.
So with that, Stéphane, I'll turn it over to you just to kick it off with a couple of -- maybe a recap from yesterday, and we -- and Alec, I can get right into questions after that.
Great. Super. Thanks, Geoff, and thanks for having us. So good morning or good afternoon, everybody. I think a quick recap of the Annual R&D Day of Moderna, which happened yesterday. On the vaccine front, we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
